Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Oxidative tissue injury in multiple sclerosis is only partly reflected in experimental disease models.
Molecular triggers of neuroinflammation in mouse models of demyelinating diseases.
Understanding Biomarkers of Neurodegeneration: Ultrasensitive detection techniques pave the way for mechanistic understanding.
Long-term treatment risks in multiple sclerosis: risk knowledge and risk perception in a large cohort of mitoxantrone-treated patients.
Fluoxetine prevents oligodendrocyte cell death by inhibiting microglia activation after spinal cord injury.
Elevated plasma high-mobility group box 1 protein is a potential marker for neuromyelitis optica.
PDE4B as a microglia target to reduce neuroinflammation.
Sexual disparities in the incidence and course of MS.
Dissection of a Complex Disease Susceptibility Region Using a Bayesian Stochastic Search Approach to Fine Mapping.
Cerebral regulatory T cells restrain microglia/macrophage-mediated inflammatory responses via IL-10.
[Neurology at the border of centuries: achievements and prospects].
Evidence for the efficacy and effectiveness of THC-CBD oromucosal spray in symptom management of patients with spasticity due to multiple sclerosis.
Oropharyngeal dysphagia in patients with multiple sclerosis: do the disease classification scales reflect dysphagia severity?
Reliability and Validity of PROMIS Cognitive Abilities and Cognitive Concerns Scales Among People with Multiple Sclerosis.
Accuracy of Postcontrast 3D Turbo Spin Echo MR Sequence for the Detection of Enhanced Inflammatory Lesions in Patients with Multiple Sclerosis.
Acute Transverse Myelitis Associated With Human Parvovirus B19 Infection.
A wireless body measurement system to study fatigue in multiple sclerosis.
Vestibular-evoked myogenic potentials, clinical evaluation, and imaging findings in multiple sclerosis.
Use of a Standardized MxA Protein Measurement-Based Assay for Validation of Assays for the Assessment of Neutralizing Antibodies Against Interferon-β
Cerebrospinal fluid myelin basic protein is frequently ordered but has little value: a test utilization study.
Disability and Fatigue Can Be Objectively Measured in Multiple Sclerosis.
Development of a cell-based assay for the detection of anti-aquaporin 1 antibodies in neuromyelitis optica spectrum disorders.
Novel insights into the development and maintenance of the blood-brain barrier.
Anxiety and depressive symptoms in caregivers of multiple sclerosis patients: The role of information processing speed impairment.
Pediatric Urinary Retention in the Emergency Department: A Concerning Symptom with Etiology Outside the Bladder.
Pages
« first
‹ previous
…
288
289
290
291
292
293
294
295
296
…
next ›
last »